Home / About Us / News

Geistlich Pharma becomes exclusive distribution partner for NUsurface®

Geistlich Pharma's Surgery business unit becomes the exclusive distribution partner for the NUsurface® meniscus implant in Switzerland and enters into an exclusive partnership with Active Implants. The objective of both companies is to support pain patients by preserving joints.
September 13, 2021

The NUsurface® meniscus implant from Active Implants is a meniscus replacement for patients with persistent knee pain after surgery on the medial meniscus. In individual cases, the meniscus replacement can close the gap between minimally invasive meniscus repair and complete knee replacement and thus prevent pronounced pain in the long term. NUsurface® is made of polycarbonate urethane (PCU), a medical plastic.

Implant mimics the function of the meniscus

Its unique material and composite structure and design require no fixation to bone or soft tissue. The superior feature is that the implant mimics the function of the natural meniscus, distributing the loads transmitted through the knee joint. The NUsurface® meniscus implant has been used in Europe since 2008 and in Israel since 2011 under CE registration.

Careful training of future users

For the introduction of the NUsurface® meniscus implant Geistlich follows its proven "No Train - No Use" approach. This involves future users going through a carefully structured training programme. The kick-off meeting was recently held with a handful of pioneer users, followed by a training programme at the Anatomical Institute of the Lucerne Cantonal Hospital. It is hoped that the circle of qualified physicians will be continuously expanded to include experienced specialists, thus enabling more patients in Switzerland to benefit from the implant.